Effect of prior year pulmonary exacerbation (PE) frequency on response to ARD-3150 in patients with non-cystic fibrosis bronchiectasis (NCFB) chronically infected with Pseudomonas aeruginosa (PA)
J. Chalmers (Dundee, United Kingdom), B. Thompson (Owings Mills, MD , United States of America), J. Froehlich (Hayward, CA, United States of America), A. Davis (Research Triangle Park, NC, United States of America), J. Dahms (Hayward, CA, United States of America), D. Cipolla (Hayward, CA, United States of America), I. Gonda (Hayward, CA, United States of America)
Source: International Congress 2018 – Improving the quality of life of patients with bronchiectasis
Disease area: Respiratory infections
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Chalmers (Dundee, United Kingdom), B. Thompson (Owings Mills, MD , United States of America), J. Froehlich (Hayward, CA, United States of America), A. Davis (Research Triangle Park, NC, United States of America), J. Dahms (Hayward, CA, United States of America), D. Cipolla (Hayward, CA, United States of America), I. Gonda (Hayward, CA, United States of America). Effect of prior year pulmonary exacerbation (PE) frequency on response to ARD-3150 in patients with non-cystic fibrosis bronchiectasis (NCFB) chronically infected with Pseudomonas aeruginosa (PA). 2675
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: